Develop inhaled respiratory medicines that are safe, effective and improve the health and quality of life in patients with asthma, obstructive pulmonary disease (COPD), and other respiratory diseases.
Develop inhaled respiratory medicines with commercially attractive target product profiles that address the unmet medical needs of patients with asthma and COPD, two of the largest growth markets in the foreseeable future.
Create shareholder value through timely execution
of our development plans and effectively managing our financial
and human resources.
Treat our employees and customers with respect and
conduct our business in an ethical and responsible manner.
